SGLT-2

Thiazolidinediones

Metformin

Sulfonylureas

Meglitinides

DPP-4 inhibitors

Therapeutic Targets

• HbA1C <7% (estimated average glucose, 154 mg/dl)
• (Pre-meal Blood sugar < 7.2 mmol/L and Post Meal < 10 mmol/L)
• BP <130/80 mmHg for CKD without proteinuria
• LDL-C <100 mg/dL ( LDL 2.6mmol/L)
• Fasting serum TG 1.6 mmol/L
• BMI 18.5–24.9 kg/m2

Alpha-glucosidase inhibitors